H₂O₂-treated <i>M</i>. <i>aeruginosa</i> forward scatter (FSC) and side scatter (SSC) relative to control. حسب Emma T. Brentjens (17295999)

الموضوعات:

<i>M</i>. <i>aeruginosa</i> treatment chemicals and doses. حسب Emma T. Brentjens (17295999)

الموضوعات:

Cyanobacteria growth of treated and control cells. حسب Emma T. Brentjens (17295999)

الموضوعات:

Dose dependent changes in fluorescence and forward scatter from cyanobacteria treated with H₂O₂. حسب Emma T. Brentjens (17295999)

الموضوعات:

Fluorescence intensity curves of control and 750 μg/mL H₂O₂ <i>M</i>. <i>aeruginosa</i> samples from UV, violet, blue, yellow-green, and red laser excitation.... حسب Emma T. Brentjens (17295999)

الموضوعات:

Fluorescence intensity curves of control and 750 μg/mL H₂O₂ <i>M</i>. <i>aeruginosa</i> samples from UV, violet, blue, yellow-green, and red laser excitation.... حسب Emma T. Brentjens (17295999)

الموضوعات:

Average green and red fluorescence for three separate experiments at 48 and 72 hours after H₂O₂ exposure. حسب Emma T. Brentjens (17295999)

الموضوعات:

Fluorescence intensity curves of <i>M</i>. <i>aeruginosa</i> after H₂O₂ and light treatments from UV, violet, blue, yellow-green, red laser excitation. حسب Emma T. Brentjens (17295999)

الموضوعات:

Mean red and green fluorescence intensity data from three experiments of cyanobacteria. حسب Emma T. Brentjens (17295999)

الموضوعات:

Pattern of <i>M</i>. <i>aeruginosa</i> fluorescence change with exposure to 750 μg/mL H₂O₂. حسب Emma T. Brentjens (17295999)

الموضوعات:

Fluorescence intensity curves of <i>M</i>. <i>aeruginosa</i> treated with PSII inhibitory chemicals from violet, blue, and yellow-green laser excitation. حسب Emma T. Brentjens (17295999)

الموضوعات:

Ratio of forward scatter (FSC) and side scatter (SSC) to control in <i>M</i>. <i>aeruginosa</i> exposed to H₂O₂ and UV, blue, and green light. حسب Emma T. Brentjens (17295999)

الموضوعات:

Red and green fluorescence of <i>M</i>. <i>aeruginosa</i> cells exposed to H₂O₂ and UV, blue, and green light over time relative to control. حسب Emma T. Brentjens (17295999)

الموضوعات:

Trend of temperature decrease in thermogradient freezer during the night from 7:00 P.M. to 5:00 A.M. حسب Alireza Hasanfard (13919335)

Bumblebees were subjected to 5 day exposure to Imidacloprid and/or/none twice daily 670 nm. حسب Michael Barry Powner (11337243)

"…As with respiration we then asked what 670nm duration was needed for correction B. Bumblebees (≥ 20 bees per group) maintained on Imidacloprid were exposed to 670nm light for 0.5, 1, 5, 15 or 60mins. …"

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease حسب Huashen Xu (13987046)

"…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …"

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease حسب Huashen Xu (13987046)

"…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …"

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease حسب Huashen Xu (13987046)

"…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …"

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease حسب Huashen Xu (13987046)

"…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …"

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. حسب Luca G. Valente (12463057)